Daily 1-pager M&A Snapshot for Deal Makers
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments
Source
Author: unknown
21 Invest Mulls Sale of $500M Eye-Care Firm Sifi - IntroductionIn a move that could reshape the eye-care industry, Italian private equity firm 21 Invest is reportedly considering the sale of Sifi,...
AbbVie's Transformative Acquisition of Cerevel Therapeutics AbbVie's $8.7 billion acquisition of Cerevel Therapeutics is set to reshape the neuroscience landscape, unlocking innovative therapies and...
Rite Aid's Elixir Buyer Must Pay Additional $50M in Ch. 11 Sale In a pivotal move for its bankruptcy restructuring, embattled pharmacy chain Rite Aid has secured an additional $50 million from...
Pieris Pharma Stock Surges on Palvella Therapeutics Merger Deal Pieris Pharmaceuticals (PIRS) saw its stock soar by over 70% on July 24, 2024, following the announcement of an all-stock merger deal...